Titre:
  • Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Auteur:Oyharcabal-Bourden, V; Kalifa, C; Gentet, J C; Frappaz, D; Edan, C; Chastagner, P; Sariban, Eric; Pagnier, A; Babin, A; Pichon, F; Neuenschwander, S; Vinchon, Mathieu; Bours, D; Mosseri, V; Le Gales, C; Ruchoux, Marie-Magdeleine; Carrie, C.; Doz, F
Informations sur la publication:Journal of clinical oncology, 23, 21, page (4726-4734)
Statut de publication:Publié, 2005-07
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Antineoplastic Agents -- administration & dosage
Antineoplastic Agents, Phytogenic -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Brain -- radiation effects
Carboplatin -- administration & dosage
Cerebellar Neoplasms -- mortality
Cerebellar Neoplasms -- radiotherapy
Chemotherapy, Adjuvant
Child
Child, Preschool
Combined Modality Therapy
Etoposide -- administration & dosage
Female
Humans
Male
Medulloblastoma -- mortality
Medulloblastoma -- radiotherapy
Radiotherapy Dosage
Spinal Canal -- radiation effects
Survival Rate
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2005.00.760
info:pii/23/21/4726
info:pmid/16034048